Table of Contents
Cover image
Systemic 131I-BA52 as a novel approach for the therapy of malignant melanoma is of considerable potential, as shown in these pre- and posttherapeutic 18F-FDG PET images. See page 9.
Systemic 131I-BA52 as a novel approach for the therapy of malignant melanoma is of considerable potential, as shown in these pre- and posttherapeutic 18F-FDG PET images. See page 9.
